DSM PTG (Formerly The Polymer Technology Group) is the technology leader in bringing new specialty chemicals and polymer-based solutions to critical material intensive applications in medical and related fields. DSM PTG's combined experience in biomaterials and medical devices offers your company support in material design and selection, synthesis and characterization, prototype fabrication and manufacturing of components and medical devices.

Company Overview

PTG has been making a difference since 1989 when founders Robert Ward, Kathleen White, and Robert Devaney recognized the future importance of biomaterials and their life-improvement and life-saving applications. Together, they bring extensive experience in polymer synthesis and Class III medical device development and manufacturing.

DSM PTG is a leader in the commercialization of specialty and biomedical polymer products. The company has the expert staff and state-of-the-art facilities to achieve high-quality synthesis, characterization, processing, regulatory approval, and manufacturing of polymer products and medical device components. DSM PTG's vertically integrated research-through-development approach enables the entire process-from invention to market launch — to be performed under one roof.

The company offers research services in the areas of polymers, materials, and medical devices and components. In addition to offering fully integrated materials-intensive device development programs, DSM PTG can also compliment a customer's in-house capabilities by providing services targeted to meet its specific needs. This could include polymer design, synthesis and characterization, materials selection, process development, device development, prototyping, and high volume manufacturing.

DSM PTG-developed-and-produced polyurethanes and other materials are most often used in the manufacturing of chronically implanted medical devices-such as pacemakers, sensing devices, ventricular-assist devices and blood pumps, spinal devices, and central venous catheters.